Safety and immunogenicity of heterologous Ad26.ZEBOV and MVA-BN®-Filo prime-boost Ebola vaccines: 6-month follow-up of a Phase I randomized trial in healthy adults
| Autor: | Kerstin Luhn, Benoit Christophe Stephan Callendret, Neil Goldstein, Carla Truyers, Stephan Bart, Wilbert Van Duijnhoven, Macaya Douoguih |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Ebola vaccine Epidemiology business.industry Immunogenicity Immunology Public Health Environmental and Occupational Health Heterologous Prime boost Virology Microbiology QR1-502 law.invention 03 medical and health sciences 030104 developmental biology Infectious Diseases Randomized controlled trial law Medicine Public aspects of medicine RA1-1270 business Month follow up |
| Zdroj: | Journal of Virus Eradication, Vol 2, Iss, Pp 10-11 (2016) |
| ISSN: | 2055-6640 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|